Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
15,024
archived clinical trials in
Infectious Disease

A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
Effect of Moderate Liver Impairment on the Pharmacokinetics of Saquinavir After Administration of Saquinavir/Ritonavir 1000/100mg BID in HIV Patients
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Voorhees, NJ
A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
Effect of Moderate Liver Impairment on the Pharmacokinetics of Saquinavir After Administration of Saquinavir/Ritonavir 1000/100mg BID in HIV Patients
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Voorhees, NJ
Click here to add this to my saved trials
A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
Effect of Moderate Liver Impairment on the Pharmacokinetics of Saquinavir After Administration of Saquinavir/Ritonavir 1000/100mg BID in HIV Patients
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Philadelphia, PA
A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
Effect of Moderate Liver Impairment on the Pharmacokinetics of Saquinavir After Administration of Saquinavir/Ritonavir 1000/100mg BID in HIV Patients
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Philadelphia, PA
Click here to add this to my saved trials
A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
Effect of Moderate Liver Impairment on the Pharmacokinetics of Saquinavir After Administration of Saquinavir/Ritonavir 1000/100mg BID in HIV Patients
Status: Enrolling
Updated:  2/28/2018
Clinical Research Facility
mi
from
Dallas, TX
A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
Effect of Moderate Liver Impairment on the Pharmacokinetics of Saquinavir After Administration of Saquinavir/Ritonavir 1000/100mg BID in HIV Patients
Status: Enrolling
Updated: 2/28/2018
Clinical Research Facility
mi
from
Dallas, TX
Click here to add this to my saved trials
A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
Effect of Moderate Liver Impairment on the Pharmacokinetics of Saquinavir After Administration of Saquinavir/Ritonavir 1000/100mg BID in HIV Patients
Status: Enrolling
Updated:  2/28/2018
mi
from
Ottawa,
A Study of Saquinavir/Ritonavir in Liver-Impaired Patients With HIV Infection.
Effect of Moderate Liver Impairment on the Pharmacokinetics of Saquinavir After Administration of Saquinavir/Ritonavir 1000/100mg BID in HIV Patients
Status: Enrolling
Updated: 2/28/2018
mi
from
Ottawa,
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Precision Trials AZ
mi
from
Phoenix, AZ
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Precision Trials AZ
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
The Women's Clinical, P.A.
mi
from
Little Rock, AR
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
The Women's Clinical, P.A.
mi
from
Little Rock, AR
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Women's Health Care Research Corp.
mi
from
San Diego, CA
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Women's Health Care Research Corp.
mi
from
San Diego, CA
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Olympian Clinical Research
mi
from
Clearwater, FL
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Olympian Clinical Research
mi
from
Clearwater, FL
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Women's Medical Research
mi
from
Clearwater, FL
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Women's Medical Research
mi
from
Clearwater, FL
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Altus Research
mi
from
Lake Worth, FL
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Altus Research
mi
from
Lake Worth, FL
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
New Age Medical Research Corporation
mi
from
Miami, FL
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
New Age Medical Research Corporation
mi
from
Miami, FL
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Augusta University
mi
from
Augusta, GA
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Clinical Trials Management
mi
from
Metairie, LA
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Clinical Trials Management
mi
from
Metairie, LA
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Wayne State University
mi
from
Detroit, MI
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Wayne State University
mi
from
Detroit, MI
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Saginaw Valley Medical Research Group, LLC
mi
from
Saginaw, MI
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Saginaw Valley Medical Research Group, LLC
mi
from
Saginaw, MI
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Alliance Women's Research Group LLC
mi
from
Delran, NJ
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Alliance Women's Research Group LLC
mi
from
Delran, NJ
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Lawrence OB-GYN Clinical Research, LLC
mi
from
Lawrenceville, NJ
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Lawrence OB-GYN Clinical Research, LLC
mi
from
Lawrenceville, NJ
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Soffolk OB/GYN
mi
from
Port Jefferson, NY
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Soffolk OB/GYN
mi
from
Port Jefferson, NY
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Eastern Carolina Women's Center
mi
from
New Bern, NC
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Eastern Carolina Women's Center
mi
from
New Bern, NC
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Hawthorne Medical Research, Inc.
mi
from
Winston-Salem, NC
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Hawthorne Medical Research, Inc.
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Unified Women's Clinical Research - Hickory
mi
from
Winston-Salem, NC
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Unified Women's Clinical Research - Hickory
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Women's Health Research
mi
from
Columbus, OH
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Women's Health Research
mi
from
Columbus, OH
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Drexel University
mi
from
Philadelphia, PA
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Drexel University
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
TMC Life Research, Inc
mi
from
Houston, TX
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
TMC Life Research, Inc
mi
from
Houston, TX
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Tidwewater Physicians for Women
mi
from
Norfolk, VA
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Tidwewater Physicians for Women
mi
from
Norfolk, VA
Click here to add this to my saved trials
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  2/28/2018
Seattle Women's Health, Research and Gynecology
mi
from
Seattle, WA
Non-Interventional Extension to Investigate Recurrence of Vulvovaginal Candidiasis and Candida Colonization
A Non-Interventional Extension Study to Investigate Vulvovaginal Candidiasis Recurrence and Candida Colonization Following a Phase 2 Randomized, Active-Controlled Study of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 2/28/2018
Seattle Women's Health, Research and Gynecology
mi
from
Seattle, WA
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
The Women's Clinical, P.A.
mi
from
Little Rock, AR
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
The Women's Clinical, P.A.
mi
from
Little Rock, AR
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Unified Women's Clinical Research - Hickory
mi
from
Winston-Salem, NC
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Unified Women's Clinical Research - Hickory
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
TMC Life Research, Inc
mi
from
Houston, TX
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
TMC Life Research, Inc
mi
from
Houston, TX
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Precision Trials AZ
mi
from
Phoenix, AZ
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Precision Trials AZ
mi
from
Phoenix, AZ
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Olympian Clinical Research
mi
from
Clearwater, FL
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Olympian Clinical Research
mi
from
Clearwater, FL
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Women's Medical Research
mi
from
Clearwater, FL
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Women's Medical Research
mi
from
Clearwater, FL
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Hawthorne Medical Research, Inc.
mi
from
Winston-Salem, NC
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Hawthorne Medical Research, Inc.
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Seattle Women's Health, Research and Gynecology
mi
from
Seattle, WA
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Seattle Women's Health, Research and Gynecology
mi
from
Seattle, WA
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
University of Alabama at Birmingham
mi
from
Birmingham, AL
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Women's Health Care Research Corp.
mi
from
San Diego, CA
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Women's Health Care Research Corp.
mi
from
San Diego, CA
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Altus Research
mi
from
Lake Worth, FL
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Altus Research
mi
from
Lake Worth, FL
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
New Age Medical Research Corporation
mi
from
Miami, FL
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
New Age Medical Research Corporation
mi
from
Miami, FL
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Augusta University
mi
from
Augusta, GA
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Augusta University
mi
from
Augusta, GA
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Clinical Trials Management
mi
from
Metairie, LA
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Clinical Trials Management
mi
from
Metairie, LA
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Saginaw Valley Medical Research Group, LLC
mi
from
Saginaw, MI
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Saginaw Valley Medical Research Group, LLC
mi
from
Saginaw, MI
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Lawrence OB-GYN Clinical Research, LLC
mi
from
Lawrenceville, NJ
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Lawrence OB-GYN Clinical Research, LLC
mi
from
Lawrenceville, NJ
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Eastern Carolina Women's Center
mi
from
New Bern, NC
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Eastern Carolina Women's Center
mi
from
New Bern, NC
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Clinical Trials of Texas, Inc.
mi
from
San Antonio, TX
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Tolan Park Clinic
mi
from
Detroit, MI
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Tolan Park Clinic
mi
from
Detroit, MI
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Alliance Women's Research Group LLC
mi
from
Delran, NJ
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Alliance Women's Research Group LLC
mi
from
Delran, NJ
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
ProHEALTH Care Associates LLP
mi
from
Port Jefferson, NY
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
ProHEALTH Care Associates LLP
mi
from
Port Jefferson, NY
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Aventiv Research
mi
from
Columbus, OH
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Aventiv Research
mi
from
Columbus, OH
Click here to add this to my saved trials
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated:  3/1/2018
Drexel University College of Medicine
mi
from
Philadelphia, PA
RADIANT: CD101 vs Standard of Care in Subjects With Acute Vaginal Yeast Infections
A Phase 2, Multicenter, Randomized, Active-controlled Study of the Safety and Tolerability of Two Formulations of CD101 Compared to Fluconazole for the Treatment of Moderate to Severe Episodes of Acute Vulvovaginal Candidiasis
Status: Enrolling
Updated: 3/1/2018
Drexel University College of Medicine
mi
from
Philadelphia, PA
Click here to add this to my saved trials